Derivatives of aziridine-2-carboxamide as inhibitors of thioredoxin reductase, their synthesis, anti-cancer and anti-metastatic effect
LV15503A
2h-selenopheno[3,2-h]chromenes for prevention and treatment of cancer
LV15498A
Derivatives of oxathiino[6,5-b]pyridine 2,2-dioxide as inhibitors of carbonic anhydrases, their synthesis and anti-cancer effect
LV15485A
Selenophene chromenone hydroxamic acids, their production and use in angiogenesis inhibition
LV15473A
Heteroaryldihydropyrimidines as hbv capsid self-assembly modulators
LV15463A
3-quinoline carboxilic acid-1,4,5,6,7,8-hexahydro-2-methyl-5-oxo-4-(2-thienyl) esters as the free fatty acid family ffar3 receptor selective ligands and syntons for creating new ligands
LV15384A
1-acetyl-5-nitro-4-phenyl-3-pyrrolin-2-one for use in the treatment of cancer
LV15347A
Novel biologically active enaminoester derivatives as agents for chemotherapy
LV15257A
Novel n-acyl-arylsulfonamide derivates as aminoacyl-trna synthetase inhibitors
LV15201A
The method for the preparation of ibrutinib intermediate
LV15206A
Method for diagnosis of insulin resistance, using measurement of the concentration of acylcarnitines in the blood
LV15181A
1,4-dihydropyridine derivative for prevention of diabetic conditions of dna breaks
LV15160A
Derivatives of 2,6-diaza-bicyclo[2.2.2]octane-3,5-ditione as potential anti-cancer agents
LV15146A
N-acyl-diarylsulfonamide derivatives as aminiacyl-t-rna synthetase inhibitors
LV15073A
Novel compounds for effective protein transfection in eukaryotic cells
LV15004A
5-(4-chlorobuthyl)-pyrano[2,3-d]pyrimidin-2,4,7(3h)-trione and 5-alkyl-2-thioxo-1h-pyrano[2,3-d]pyrimidin-4,7-dione as novel selective ligands and synthons of hydroxycarboxylic acid hca2 (grp109a) classes receptors
LV15002A
Substituted heterocycle [(2-carboxy or -methoxycarbonyl)phenylcarbamoyl-methyl (or trimethylen)]-pyridinium or isoquinolinium bromides as hydroxycarboxylic acid receptor (hca2) family novel class of ligands
LV15003A
A pharmaceutical composition for the control of weight gain
